-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IAG-933 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. IAG-933 in Solid Tumor Drug Details: IAG-933 is under development for the treatment of...
-
Company Insights
![]()
Insurance Australia Group – Digital Transformation Strategies
Insurance Australia Group (IAG) Digital Transformation Strategies Report Overview Insurance Australia Group (IAG) is tapping into key disruptive technologies, including AI, big data, cloud, and cybersecurity, among others, to digitally transform its operations. The annual ICT spending of IAG is estimated at $215.9 million for 2023. A major share of this spending is earmarked for acquiring software, network and communications, and hardware from vendors. IAG is a general insurance company operating in Australia and New Zealand. In Australia, the company’s...
-
Track & Monitor
New![]()
Banking and Payments Venture Capital Investments in Q2 2023
GlobalData's Banking & Payments (B&P) VentureView report provides detailed coverage of the global venture capital investment activity in Banking & Payments industry in Q3 2023, covering key insights and trends.
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TQB-3454 in Astrocytoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TQB-3454 in Astrocytoma Drug Details: TQB-3454 is under development for the treatment of metastatic solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ABBV-368 in Renal Cell Carcinoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.ABBV-368 in Renal Cell Carcinoma Drug Details:ABBV-368 is under development for the treatment of solid tumors...
-
Product Insights
![]()
IAG – 522 University Mixed-Use Condominium Building – Ontario
Equip yourself with the essential tools needed to make informed and profitable decisions with our IAG - 522 University Mixed-Use Condominium Building - Ontario report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Company Profile
![]()
Insurance Australia Group Ltd – Company Profile
Insurance Australia Group Ltd (IAG) is a provider of general insurance. The group, through its subsidiaries, provides an array of personal and commercial insurance products. It offers insurance products for commercial and motor fleet, commercial liability, commercial property, home and contents, construction and engineering, and marine. The group also offers travel insurance, income protection insurance, farm, crop and livestock insurance, commercial liability insurance, personal liability insurance, professional indemnity insurance, rural and horticultural insurance and workers' compensation insurance. The group markets...
Add to Basket -
Company Profile
![]()
International Consolidated Airlines Group SA – Company Profile
International Consolidated Airlines Group SA (IAG) is an airline holding company. It offers scheduled passenger air transportation services at domestic and international levels. The company operates Aer Lingus, British Airways, Iberia, LEVEL, and Vueling airlines. IAG also provides air cargo and aircraft related information technology services. The company offers aircraft maintenance and airport handling operations, which include repairs and maintenance of aircraft engines and components. IAG offers travel rewards and experience programs under the Avios brand. It carries out operations...
Add to Basket -
Sector Analysis
![]()
Spain Source Tourism Insight by Domestic and Outbound Tourism, Key Destinations and Tourist Profiles, 2023 Update
GlobalData’s "Spain Source Tourism Insight Report including International Departures, Domestic Trips, Key Destinations, Trends, Tourist Profiles, Analysis of Consumer Survey Responses, Spend Analysis, Risks and Future Opportunities, 2023 Update" report provides a thorough insight into the Spain's domestic and outbound tourism market. The report looks at the profiles of Spanish tourists and summarizes the key reasons that they travel. The report offers an in-depth analysis of traveler flows, spending patterns, main destination markets and current and future opportunities for tourism...
-
Thematic Analysis
![]()
Social Responsibility Trends in Travel and Tourism – Thematic Intelligence
This report analyzes the impact of social responsibility pressures on the Travel & Tourism sector. Who Should Buy Senior executives and ESG executives in Travel & Tourism industry.
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.